Oral health in liver transplant children administered cyclosporin A or tacrolimus

International Journal of Paediatric Dentistry

Volumn 11, Issue 6, 2001, Pages 424-429

  Wondimu, B ^a   Nemeth A ^b   Modeer T ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN; IMMUNOSUPPRESSIVE AGENT; TSUKUBAENOLIDE;

ADOLESCENT; ADULT; ARTICLE; BILE DUCT ATRESIA; CHILD; CONGENITAL MALFORMATION; DRUG EFFECT; ENAMEL; ENAMEL HYPOPLASIA; FEMALE; FOLLOW UP; GINGIVA OVERGROWTH; GINGIVITIS; HEALTH SURVEY; HUMAN; HYPERBILIRUBINEMIA; IATROGENIC DISEASE; LIVER TRANSPLANTATION; MALE; MOUTH DISEASE; NONPARAMETRIC TEST; PERIODONTAL DISEASE; PERIODONTICS; PERIODONTITIS; PRESCHOOL CHILD; TOOTH COLOR; TOOTH DISEASE; TOOTH PLAQUE;

ADOLESCENT; ADULT; BILIARY ATRESIA; CHILD; CHILD, PRESCHOOL; CYCLOSPORINE; DENTAL ENAMEL; DENTAL ENAMEL HYPOPLASIA; DENTAL PLAQUE INDEX; DMF INDEX; FEMALE; FOLLOW-UP STUDIES; GINGIVAL OVERGROWTH; GINGIVITIS; HUMAN; HYPERBILIRUBINEMIA; IMMUNOSUPPRESSIVE AGENTS; LIVER TRANSPLANTATION; MALE; MOUTH DISEASES; PERIODONTAL ATTACHMENT LOSS; PERIODONTAL INDEX; PERIODONTAL POCKET; STATISTICS; STATISTICS, NONPARAMETRIC; SUPPORT, NON-U.S. GOV'T; TACROLIMUS; TOOTH DISCOLORATION; TOOTH DISEASES;

EID: 0035515781     PISSN: 09607439     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.0960-7439.2001.00305.x     Document Type: Article

References (30)

1. Goss JA, Shackleton CR, McDiarmid SV et al. Long-term results of paediatric liver transplantation: an analysis of 569 transplants. Annals of Surgery 1998; 228: 411-420.
2. Reding R, Gennari F, Janssen M et al. The paediatric liver transplant program at the Université Catholique de Louvain, Cliniques Saint-Luc, Brussels: overall results in 444 children (1984-97). Acta Gastroenterologica Belgica 1999; 62: 285-289.
3. Funakoshi Y, Ohshita C, Moritani Y, Hieda T. Dental findings of patients who underwent liver transplantation. Journal of Clinical Paediatric Dentistry 1992; 16: 259-262.
4. Seow WK, Shepherd RW, Ong TH. Oral changes associated with end-stage liver disease and liver transplantation: implications for dental management. Journal of Dentistry for Children 1991; 58: 474-480.
5. Ross PJ, Nazif MM, Zullo T, Zitelli B, Guevara P. Effects of cyclosporin A on gingival status following liver transplantation. Journal of Dentistry for Children 1989; 56: 56-59.
6. Allman SD, McWhorter AG, Seale NS. Evaluation of cyclosporin-induced gingival overgrowth in the paediatric transplant patient. Pediatric Dentistry 1994; 16: 36-40.
7. Hunt SA, Gamberg P, Stinson EB, Oyer PE, Shumway NE. The Stanford experience: survival and renal function in the pre-sandimmune era compared to the sandimmune era. Transplantation Proceedings 1990; 22: 1-5.
8. Feutren G. Clinical experience with sandimmune (cyclosporin) in autoimmune diseases. Transplantation Proceedings 1992; 24: 55.
9. Hamilton DV, Evans DB, Thiru S. Toxicity of cyclosporin A in organ grafting. In: White D (ed.). Cyclosporin A. Amsterdam: Elsevier, 1982: 393-411.
10. Rateitschak-Plüss E, Heft A, Lörtscher R, Thiel G. Initial observation that cyclosporin-A induces gingival enlargement in man. Journal of Clinical Periodontology 1983; 10: 237-246.
11. Todo S, Fung JJ, Tzakis A. One hundred and ten consecutive primary orthotopic liver transplants under FK506 in adults. Transplantation Proceedings 1991; 23: 1397-1402.
12. Liver EF. European FK506 Multicentre Liver Study Group. Randomised trial comparing tacrolimus (FK506) and cyclosporin in prevention of liver allograft rejection. Lancet 1994; 334: 423-428.
13. Shapiro R, Jordan ML, Scantlebry VP et al. A prospective randomized trial of FK506-based immunosuppression after renal transplantation. Transplantation 1995; 59: 485-490.
14. Pham SM, Kormos RL, Hattler BG. A prospective trial of tacrolimus (FK506) in clinical heart transplantation: intermediate-term results. Journal of Thoracic and Cardiovascular Surgery 1996; 111: 764-769.
15. Busuttil RW, Holt CD. Tacrolimus (FK506) is superior to cyclosporin in liver transplantation. Transplantation Proceedings 1997; 29: 534-538.
16. Marks AR. Cellular functions of immunophilins. Physiological Reviews 1996; 76: 631-649.
17. Morris RE. Mechanisms of action of new immunosuppressive drugs. Therapeutic Drug Monitoring 1995; 17: 564-569.
18. Wallemacq PE, Reding R. FK506 (tacrolimus), a novel immunosuppressant in organ transplantation: clinical, biomedical, and analytical aspect. Clinical Chemistry 1993; 39: 2219-2228.
19. Group ETMRS. European Tacrolimus Multicenter Renal Study Group: multicenter randomized trial comparing tacrolimus (FK506) and cyclosporin in the prevention of renal allograft rejection. Transplantation 1997; 64: 436-443.
20. Axelsson P, Lindhe J. Effect of fluoride on gingivitis and dental caries in a preventive program based on plaque control. Community Dentistry and Oral Epidemiology 1975; 3: 56-60.
21. Wondimu B, Dahllöf G, Berg U, Modéer T. Cyclosporin A-induced gingival overgrowth in renal transplant children. Scandinavian Journal of Dental Research 1993; 101: 282-286.
22. Federation Dentaire Internationale Commission on Oral Health RaE. A review of developmental defects of enamel index (DDE Index). International Dental Journal 1992; 42: 411-426.
23. Koch G. Effect of sodium fluoride in dentifrice and mouthwash on incidence of dental caries in schoolchildren. Odontological Review 1967; 18: 13-21 (Suppl. 12).
24. Bolin A-K, Bolin A, Koch G. Children's dental health in Europe: caries experience of 5-and 12-year-old children from eight EU countries. Journal of Paediatric Dentistry 1996; 6: 155-162.
25. Hosey MT, Gordon G, Kelly DA, Shaw L. Oral findings in children with liver transplants. International Journal of Paediatric Dentistry 1995; 5: 29-34.
26. Daley TD, Wysocki GP, Day C. Clinical and pharmacologic correlation in cyclosporin-induced gingival hyperplasia. Oral Surgery, Oral Medicine and Oral Pathology 1986; 62: 417-421.
27. Wondimu B, Reinholt FP, Modéer T. Steriologic study of cyclosporin A-induced gingival overgrowth in renal transplant patients. European Journal of Oral Sciences 1995; 103: 199-206.
28. Seymour RA, Smith DG. The effect of a plaque control programme on the incidence and severity of cyclosporin-induced gingival changes. Journal of Clinical Periodontology 1991; 18: 107-110.
29. Demetris AJ, Fung JJ, Todo S et al. Conversion of liver allograft recipients from cyclosporin to FK506 immunosuppressive therapy: a clinicopathologic study of 96 patients. Transplantation 1992; 53: 1056-62.
30. Jams JA, Boomer S, Maxwell AP et al. Reduction in gingival overgrowth associated with conversion from cyclosporin A to tacrolimus. Journal of Clinical Periodontology 2000; 27: 144-148.